En español
NIDA

Agenda

120th Meeting of the National Advisory Council on Drug Abuse

Neuroscience Center - Conference Rooms C & D
6001 Executive Boulevard, Bethesda, MD.

WebEx Information

Topic: National Advisory Council on Drug Abuse Meeting
Date and Time:  Wednesday, May 6, 2015 8:30 am, Eastern Daylight Time (New York, GMT-04:00)
Event number: 628 968 452
Event password: Success1

To start the online event:

  1. Go to https://nih.webex.com/nih/onstage/g.php?d=628968452&t=a
  2. If requested, enter in your name and email address.
  3. If a password is required, enter in the meeting password:  Success1
  4. Click “Join”.

Audio Conference Information

May 6, 2015

Open Session

8:30 a.m. Opening and Welcome New Members
Nora Volkow, M.D. Director, NIDA
8:45 a.m. Director's Report
Nora Volkow, M.D. Director, NIDA
9:45 a.m. Council Discussion
Council Members
10:00 a.m. Big Data: NIH initiatives
Philip E. Bourne, Ph.D.
Associate Director for Data Science, (ADDS), NIH
10:45 a.m. Break
11:00 a.m. NIDA’s Strategic Plan: Update
Maureen Boyle, Ph.D.
Chief, Science Policy Branch
Office of Science Policy and Communications, NIDA
11:30 a.m. DCNBR Portfolio Analysis, NIDA Council Subcommittee
John Rotrosen, M.D.
Professor Department of Psychiatry
New York University School of Medicine
NACDA Council Member
12:00 p.m. Lunch Break
1:00 p.m.

FDA Role in Marijuana Research and Regulations
Douglas Throckmorton, M.D.
Deputy Center Director for Regulatory Programs,
FDA

1:45 p.m. Public Comments
2:00 p.m. Adjourn

Closed Session

This meeting is closed to the public in accordance with the provisions set forth in section 552b{c} and 552b{c}(6), Title 5, U.S. Code and section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2).

1:00 p.m.

Call to Order
Nora Volkow, M.D. Director, NIDA

Review of Policy and Procedures
Susan Weiss, Ph.D.,
Executive Secretary,
National Advisory Council on Drug Abuse,
Director, Division of Extramural Research, NIDA

1:15 p.m.

Council Review of Grant Applications
Nora Volkow, M.D., Director, NIDA

Division of Pharmacotherapies and Medical Consequences of Drug Abuse
Phil Skolnick, Ph.D., D.Sc. (hon.), Director

Division of Basic Neuroscience and Behavioral Research
Joni Rutter, Ph.D., Director

Division of Clinical Neuroscience and Behavioral Research
Joseph Frascella, Ph.D., Director

Division of Epidemiology, Services, and Prevention Research
Redonna Chandler, Ph.D., Acting Director

Center for Clinical Trials Network
Betty Tai, Ph.D., Director

Office of Translational Initiatives and Programs
Elena Koustova, Ph.D., M.B.A., Director

2:15 p.m. Request for Subcommittee Members: Updating “Points to Consider Document”
Susan Weiss, Ph.D.,
Executive Secretary,
National Advisory Council on Drug Abuse,
Director, Division of Extramural Research, NIDA
2:30 p.m. End of Closed Session/Break

This page was last updated May 2015